Live Breaking News & Updates on Foundation Trust In Surrey

Stay updated with breaking news from Foundation trust in surrey. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Clinical trial confirms breakthrough treatment for COVID-19: Patients with a self-administered nasal spray found to have reduced SARS-CoV-2 viral load by more than 95% in infected participants within 24 hours


Clinical trial confirms breakthrough treatment for COVID-19: Patients with a self-administered nasal spray found to have reduced SARS-CoV-2 viral load by more than 95% in infected participants within 24 hours
Posted on
ADVERTISEMENT
Patients with a self-administered nasal spray application found to have reduced SARS-CoV-2 log viral load by more than 95% in infected participants within 24 hours of treatment, and by more than 99% in 72 hours
Trial concluded that treatment accelerated clearance of SARS-CoV-2 by a factor of 16-fold versus a placebo
Randomized, double-blind, placebo-controlled trial evaluated 79 confirmed cases of COVID-19, the majority heavily-infected with the UK variant
No adverse events were recorded in the group ....

United Kingdom General , United Kingdom , Stephen Winchester , Sanotize Research Development Corp , Utah State University Antiviral Research Institute , Surrey Pathology Services , Foundation Trust In Surrey , Emergency Use , Columbia Biotech , Development Corp , Nitric Oxide Nasal Spray , Consultant Medical Virologist , Chief Investigator , Blue Baby Syndrome , Seeking Emergency Use Authorization , Utah State University , Antiviral Research , ஒன்றுபட்டது கிஂக்டம் ஜநரல் , ஒன்றுபட்டது கிஂக்டம் , ஸ்டீபன் வின்செஸ்டர் , சர்ரே நோயியல் சேவைகள் , அடித்தளம் நம்பிக்கை இல் சர்ரே , அவசரம் பயன்பாடு , வளர்ச்சி கார்ப் , ஆலோசகர் மருத்துவ வைராலஜிஸ்ட் , தலைமை புலனாய்வாளர் ,

Clinical trial confirms breakthrough treatment for COVID-19


Clinical trial confirms breakthrough treatment for COVID-19
Randomized, double-blind, placebo-controlled trial evaluated 79 confirmed cases of COVID-19, the majority heavily-infected with the UK variant.
ADVERTISEMENT
Patients with a self-administered nasal spray application found to have reduced SARS-CoV-2 log viral load by more than 95% in infected participants within 24 hours of treatment, and by more than 99% in 72 hours
Trial concluded that treatment accelerated clearance of SARS-CoV-2 by a factor of 16-fold versus a placebo
Randomized, double-blind, placebo-controlled trial evaluated 79 confirmed cases of COVID-19, the majority heavily-infected with the UK variant
No adverse events were recorded in the group
Submission for Emergency Use in the UK and Canada for the treatment and prevention of COVID-19 is planned immediately ....

United Kingdom General , United Kingdom , Rob Wilson , Chris Miller , Stephen Winchester , Gilly Regev , Sanotize Research Development Corp , Pt Mag Campaign , Utah State University Antiviral Research Institute , Surrey Pathology Services , Foundation Trust In Surrey , Emergency Use , Columbia Biotech , Development Corp , Nitric Oxide Nasal Spray , Consultant Medical Virologist , Chief Investigator , Blue Baby Syndrome , Seeking Emergency Use Authorization , Utah State University , Antiviral Research , Chief Science Officer , Call Willie , ஒன்றுபட்டது கிஂக்டம் ஜநரல் , ஒன்றுபட்டது கிஂக்டம் , கொள்ளை வில்சன் ,

Canadian Biotech Company's Nasal Spray Could Provide Important Breakthrough In Covid-19 Treatment; Clinical Trials In Canada And UK Show Encouraging Results


Canadian Biotech Company’s Nasal Spray Could Provide Important Breakthrough In Covid-19 Treatment; Clinical Trials In Canada And UK Show Encouraging Results
by Swarajya Staff - Apr 9, 2021 10:14 AM
Clinical trials have shown that NONS is an effective treatment.
Snapshot
NONS could prevent the transmission of Covid-19, shorten its course, as well as reduce the severity of the symptoms and damage in those already infected.
Canadian biotech company SaNOtize Research & Development Corp (SaNOtize) has developed nitric oxide nasal spray (NONS). It can protect people from viruses that enter the body through the upper nasal pathways.
According to the trial findings, this could help the world to fight the battle against the coronavirus pandemic. ....

United Kingdom General , United Kingdom , New Zealand , British Columbia , Sanotize Ashford , Stephen Winchester , Gilly Regev , Sanotize Research Development Corp , Devices Safety Authority , Surrey Pathology Services , Foundation Trust In Surrey , Development Corp , New Zealand Medicines , Medical Devices Safety Authority , Consultant Medical Virologist , Chief Investigator , ஒன்றுபட்டது கிஂக்டம் ஜநரல் , ஒன்றுபட்டது கிஂக்டம் , புதியது ஜீலாந்து , பிரிட்டிஷ் கொலம்பியா , ஸ்டீபன் வின்செஸ்டர் , சாதனங்கள் பாதுகாப்பு அதிகாரம் , சர்ரே நோயியல் சேவைகள் , அடித்தளம் நம்பிக்கை இல் சர்ரே , வளர்ச்சி கார்ப் , புதியது ஜீலாந்து மருந்துகள் ,

Covid-19 nasal spray: Israel, New Zealand give interim approval for sale, watch how it works